Three months ended 31 Mar
Key Consolidated Statement of Comprehensive Income Items	2021 US$ mn (unaudited)	2020 US$ mn (unaudited)
Revenue	1,132	1,007
Gross Profit	317	337
Share of Profit of a 35%-owned Associate - CTI	44	-
Profit Attributable to Shareholders	137	133
Profit Attributable to Shareholders before Biological Assets Fair Value Changes	161	158
	As at 31 Mar 2021	As at 31 Dec 2020
Key Consolidated Statement of Financial Position Items	(unaudited) US$ mn	(audited) US$ mn
Property, Plant & Equipment	1,603	1,589
Investment in Associates	2,367	2,331
Total Assets	6,733	6,597
Bank Borrowings & Corporate Bond	1,035	1,136
Issued Capital	253	253
Shareholders' Equity	3,669	3,548
Total Equity	4,211	4,033